Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.1 The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.2,3

Flu in the Golden Years: A Regional Wake-up Call

In Vietnam, annual influenza hospitalizations among the elderly are 154% higher, and mortality rates 700% higher than in adults aged 50-64. Yet vaccination coverage in those 65 and older remains just 5.55%, well below the WHO target of 75%.

Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results

This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.

Study Overview: The analysis examines dupilumab efficacy stratified by previous treatment history, including:

- Prior or current use of swallowed topical corticosteroids (STCs) 
- Concomitant proton pump inhibitor (PPI) treatment 
- History of food elimination diet

Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results

This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.

Study Overview: The analysis examines dupilumab efficacy stratified by previous treatment history, including:

- Prior or current use of swallowed topical corticosteroids (STCs) 
- Concomitant proton pump inhibitor (PPI) treatment 
- History of food elimination diet

Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results

This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.

Study Overview: The analysis examines dupilumab efficacy stratified by previous treatment history, including:

- Prior or current use of swallowed topical corticosteroids (STCs) 
- Concomitant proton pump inhibitor (PPI) treatment 
- History of food elimination diet

Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results

This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.

Study Overview: The analysis examines dupilumab efficacy stratified by previous treatment history, including:

- Prior or current use of swallowed topical corticosteroids (STCs) 
- Concomitant proton pump inhibitor (PPI) treatment 
- History of food elimination diet

BEYOND THE COUGH: THE DEVASTATING IMPACT OF FLU ON SENIORS

Older adults are most vulnerable to severe influenza outcomes due to aging immune response, frailty, and comorbidities. Flu Infection worsens chronic conditions, raising risks of hospitalization and death. Influenza vaccination should be part of standard care for the elderly, especially those with chronic diseases.

Preocupaciones sobre el aumento de peso y el tratamiento con insulina

Análisis de las preocupaciones sobre el aumento de peso asociado al tratamiento con insulina en diabetes.

Preocupaciones sobre el aumento de peso y el tratamiento con insulina

Las estrategias y consejos prácticos en este artículo pueden ayudar en las conversaciones para abordar la reticencia de tus pacientes sobre el inicio de la insulina debido a sus preocupaciones sobre el aumento de peso. 

Preocupaciones sobre el aumento de peso y el tratamiento con insulina

Análisis clínico de las preocupaciones sobre el aumento de peso asociado al tratamiento con insulina en pacientes con diabetes.

Protección Flexible y Eficaz contra Virus Sincicial Respiratorio (VSR)

La temporada del Virus Sincicial Respiratorio (VSR) representa un período de alta demanda en los sistemas de salud debido a las infecciones respiratorias en lactantes. Las estrategias de prevención actuales buscan reducir el impacto de esta carga mediante la protección de los lactantes durante su período de mayor vulnerabilidad.

Beyfortus® : Protección Flexible y Eficaz contra VSR

Descubra el impacto real de inmunizar contra el virus sincicial respiratorio